Dr. Paul M. Lieberman is leader of the Genome Regulation and Cell Signaling Program at the Ellen and Ronald Caplan Cancer Center. He studies how certain viruses, such as Epstein-Barr virus (EBV), establish a long-term latent infection that can lead to cancer or autoimmune disorders. We sat down with Lieberman to talk with him about progress in EBV research. Dr. Paul M. Lieberman: I became interested in EBV during my graduate student introduction to virology. Someone explained that this virus…